Open Access496 Baseline and Longitudinal Microbial Changes Predict Response to Rifaximin and/or Diet Low in Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols in Irritable Bowel Syndrome
Author(s) -
Allen Lee,
Krishna Rao,
Emily Haller,
Lauren Van Dam,
Jason Baker,
Lydia Watts,
Shanti Eswaran,
William D. Chey,
Chung Owyang,
Vincent Young,
William L. Hasler
Publication year - 2019
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000591516.14100.44
Subject(s) - irritable bowel syndrome , medicine , rifaximin , bloating , gastroenterology , abdominal pain , diarrhea , clinical endpoint , antibiotics , randomized controlled trial , microbiology and biotechnology , biology